Halozyme Therapeutics
HALO
#1812
Rank
$11.73 B
Marketcap
$102.92
Share price
-0.69%
Change (1 day)
51.33%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : $2.43 Billion USD

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are $2.43 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$1.64 B-1.33%
2022-12-31$1.67 B84.22%
2021-12-31$0.90 B111.59%
2020-12-31$0.42 B-9.54%
2019-12-31$0.47 B147.76%
2018-12-31$0.19 B-38.58%
2017-12-31$0.31 B5.98%
2016-12-31$0.29 B111.83%
2015-12-31$0.13 B11.37%
2014-12-31$0.12 B2.33%
2013-12-31$0.12 B41.81%
2012-12-31$85.87 M56.54%
2011-12-31$54.85 M-22.73%
2010-12-31$70.99 M1.06%
2009-12-31$70.24 M14.81%
2008-12-31$61.18 M33.9%
2007-12-31$45.69 M98.58%
2006-12-31$23.01 M898.98%
2005-12-31$2.3 M45.84%
2004-12-31$1.57 M477.61%
2003-12-31$0.27 M-55.18%
2002-12-31$0.61 M18450.93%
2001-12-31$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$115.89 B 4,661.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$115.63 B 4,651.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$107.80 B 4,329.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$67.90 B 2,689.86%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
$13.61 B 459.28%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$0.79 B-67.15%๐Ÿ‡บ๐Ÿ‡ธ USA